• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 11/21/14

    • 30-Day SEC Yield1

      -0.16%
    • Total Net Assets

      $635.4M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 11/21/14

    • % of Net Assets
    • Stocks

      99.87
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.13
  • Download All HoldingsAll Holdings (%)as of 11/21/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    864,668
    86,968,30413.69
    Amgen Inc
    AMGN US
    479,219
    78,021,64812.28
    Celgene Corp
    CELG US
    598,544
    64,762,46010.19
    Biogen Idec Inc
    BIIB US
    150,962
    45,824,5167.21
    Alexion Pharmaceuticals Inc
    ALXN US
    178,910
    34,175,3885.38
    Vertex Pharmaceuticals Inc
    VRTX US
    281,536
    31,363,1104.94
    Regeneron Pharmaceuticals Inc
    REGN US
    75,274
    30,504,7884.80
    Illumina Inc
    ILMN US
    149,725
    27,823,3964.38
    Incyte Corp Ltd
    INCY US
    371,701
    26,862,8324.23
    Biomarin Pharmaceutical Inc
    BMRN US
    296,219
    25,424,4764.00
    Pharmacyclics Inc
    PCYC US
    171,960
    24,131,1463.80
    Medivation Inc
    MDVN US
    205,159
    22,419,7763.53
    Qiagen Nv
    QGEN US
    809,542
    19,048,5243.00
    United Therapeutics Corp
    UTHR US
    117,139
    15,165,9862.39
    Cubist Pharmaceuticals Inc
    CBST US
    178,878
    13,165,4212.07
    Covance Inc
    CVD US
    129,149
    13,019,5112.05
    Alkermes Plc
    ALKS US
    225,863
    12,737,5442.00
    Puma Biotechnology Inc
    PBYI US
    54,815
    12,282,9451.93
    Isis Pharmaceuticals Inc
    ISIS US
    237,057
    12,075,6841.90
    Charles River Laboratories Internationa
    CRL US
    130,129
    8,311,3391.31
    Nps Pharmaceuticals Inc
    NPSP US
    251,696
    8,054,2721.27
    Cepheid Inc
    CPHD US
    141,369
    7,462,8701.17
    Intercept Pharmaceuticals Inc
    ICPT US
    40,255
    6,234,2920.98
    Seattle Genetics Inc
    SGEN US
    119,498
    4,403,5020.69
    Myriad Genetics Inc
    MYGN US
    135,298
    4,380,9490.69
    Other/Cash
    810,0520.13
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.